Literature DB >> 20660265

Synergistic effects of long-term antioxidant diet and behavioral enrichment on beta-amyloid load and non-amyloidogenic processing in aged canines.

Viorela Pop1, Elizabeth Head, Mary-Ann Hill, Dan Gillen, Nicole C Berchtold, Bruce A Muggenburg, Norton W Milgram, M Paul Murphy, Carl W Cotman.   

Abstract

A long-term intervention (2.69 years) with an antioxidant diet, behavioral enrichment, or the combined treatment preserved and improved cognitive function in aged canines. Although each intervention alone provided cognitive benefits, the combination treatment was additive. We evaluate the hypothesis that antioxidants, enrichment, or the combination intervention reduces age-related beta-amyloid (Abeta) neuropathology, as one mechanism mediating observed functional improvements. Measures assessed were Abeta neuropathology in plaques, biochemically extractable Abeta(40) and Abeta(42) species, soluble oligomeric forms of Abeta, and various proteins in the beta-amyloid precursor protein (APP) processing pathway. The strongest and most consistent effects on Abeta pathology were observed in animals receiving the combined antioxidant and enrichment treatment. Specifically, Abeta plaque load was significantly decreased in several brain regions, soluble Abeta(42) was decreased selectively in the frontal cortex, and a trend for lower Abeta oligomer levels was found in the parietal cortex. Reductions in Abeta may be related to shifted APP processing toward the non-amyloidogenic pathway, because alpha-secretase enzymatic activity was increased in the absence of changes in beta-secretase activity. Although enrichment alone had no significant effects on Abeta, reduced Abeta load and plaque maturation occurred in animals receiving antioxidants as a component of treatment. Abeta measures did not correlate with cognitive performance on any of the six tasks assessed, suggesting that modulation of Abeta alone may be a relatively minor mechanism mediating cognitive benefits of the interventions. Overall, the data indicate that multidomain treatments may be a valuable intervention strategy to reduce neuropathology and improve cognitive function in humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660265      PMCID: PMC3769160          DOI: 10.1523/JNEUROSCI.6194-09.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  27 in total

1.  Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementia.

Authors:  K Hager; A Marahrens; M Kenklies; P Riederer; G Münch
Journal:  Arch Gerontol Geriatr       Date:  2001-06       Impact factor: 3.250

2.  Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.

Authors:  Rakez Kayed; Elizabeth Head; Jennifer L Thompson; Theresa M McIntire; Saskia C Milton; Carl W Cotman; Charles G Glabe
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

3.  ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein.

Authors:  Demian F Obregon; Kavon Rezai-Zadeh; Yun Bai; Nan Sun; Huayan Hou; Jared Ehrhart; Jin Zeng; Takashi Mori; Gary W Arendash; Doug Shytle; Terrence Town; Jun Tan
Journal:  J Biol Chem       Date:  2006-04-19       Impact factor: 5.157

4.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

5.  Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice.

Authors:  Kavon Rezai-Zadeh; Doug Shytle; Nan Sun; Takashi Mori; Huayan Hou; Deborah Jeanniton; Jared Ehrhart; Kirk Townsend; Jin Zeng; David Morgan; John Hardy; Terrence Town; Jun Tan
Journal:  J Neurosci       Date:  2005-09-21       Impact factor: 6.167

6.  Region specific neuron loss in the aged canine hippocampus is reduced by enrichment.

Authors:  Christina T Siwak-Tapp; Elizabeth Head; Bruce A Muggenburg; Norton W Milgram; Carl W Cotman
Journal:  Neurobiol Aging       Date:  2006-11-07       Impact factor: 4.673

7.  Frontal lobe volume, function, and beta-amyloid pathology in a canine model of aging.

Authors:  P Dwight Tapp; Christina T Siwak; Fu Qiang Gao; Jr-Yuan Chiou; Sandra E Black; Elizabeth Head; Bruce A Muggenburg; Carl W Cotman; Norton W Milgram; Min-Ying Su
Journal:  J Neurosci       Date:  2004-09-22       Impact factor: 6.167

8.  Size and reversal learning in the beagle dog as a measure of executive function and inhibitory control in aging.

Authors:  P Dwight Tapp; Christina T Siwak; Jimena Estrada; Elizabeth Head; Bruce A Muggenburg; Carl W Cotman; Norton W Milgram
Journal:  Learn Mem       Date:  2003 Jan-Feb       Impact factor: 2.460

9.  Neurogenesis decreases with age in the canine hippocampus and correlates with cognitive function.

Authors:  Christina T Siwak-Tapp; Elizabeth Head; Bruce A Muggenburg; Norton W Milgram; Carl W Cotman
Journal:  Neurobiol Learn Mem       Date:  2007-06-22       Impact factor: 2.877

10.  Dietary enrichment counteracts age-associated cognitive dysfunction in canines.

Authors:  N W Milgram; S C Zicker; E Head; B A Muggenburg; H Murphey; C J Ikeda-Douglas; C W Cotman
Journal:  Neurobiol Aging       Date:  2002 Sep-Oct       Impact factor: 4.673

View more
  20 in total

Review 1.  Homeostatic disinhibition in the aging brain and Alzheimer's disease.

Authors:  Marc Gleichmann; Vivian W Chow; Mark P Mattson
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

2.  Aβ vaccination in combination with behavioral enrichment in aged beagles: effects on cognition, Aβ, and microhemorrhages.

Authors:  Paulina R Davis; Ginevra Giannini; Karin Rudolph; Nathaniel Calloway; Christopher M Royer; Tina L Beckett; M Paul Murphy; Frederick Bresch; Dieter Pagani; Thomas Platt; Xiaohong Wang; Amy Skinner Donovan; Tiffany L Sudduth; Wenjie Lou; Erin Abner; Richard Kryscio; Donna M Wilcock; Edward G Barrett; Elizabeth Head
Journal:  Neurobiol Aging       Date:  2016-09-26       Impact factor: 4.673

3.  Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation.

Authors:  Ira T Lott; Eric Doran; Vinh Q Nguyen; Anne Tournay; Elizabeth Head; Daniel L Gillen
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

Review 4.  Cognitive Aging in Dogs.

Authors:  Durga Chapagain; Friederike Range; Ludwig Huber; Zsófia Virányi
Journal:  Gerontology       Date:  2017-10-25       Impact factor: 5.140

5.  Exercise and BDNF reduce Aβ production by enhancing α-secretase processing of APP.

Authors:  Saket M Nigam; Shaohua Xu; Joanna S Kritikou; Krisztina Marosi; Lennart Brodin; Mark P Mattson
Journal:  J Neurochem       Date:  2017-05-18       Impact factor: 5.372

Review 6.  A canine model of human aging and Alzheimer's disease.

Authors:  Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2013-03-23

7.  A combination cocktail improves spatial attention in a canine model of human aging and Alzheimer's disease.

Authors:  Elizabeth Head; Heather L Murphey; Amy L S Dowling; Katie L McCarty; Samuel R Bethel; Jonathan A Nitz; Melanie Pleiss; Jenna Vanrooyen; Mike Grossheim; Jeffery R Smiley; M Paul Murphy; Tina L Beckett; Dieter Pagani; Frederick Bresch; Curt Hendrix
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 8.  Dog Models of Aging.

Authors:  Audrey Ruple; Evan MacLean; Noah Snyder-Mackler; Kate E Creevy; Daniel Promislow
Journal:  Annu Rev Anim Biosci       Date:  2021-10-26       Impact factor: 8.923

9.  Dietary and behavioral interventions protect against age related activation of caspase cascades in the canine brain.

Authors:  Shikha Snigdha; Nicole Berchtold; Giuseppe Astarita; Tommy Saing; Daniele Piomelli; Carl W Cotman
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

10.  Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease.

Authors:  Hideyuki Takeuchi; Hiroyuki Mizoguchi; Yukiko Doi; Shijie Jin; Mariko Noda; Jianfeng Liang; Hua Li; Yan Zhou; Rarami Mori; Satoko Yasuoka; Endong Li; Bijay Parajuli; Jun Kawanokuchi; Yoshifumi Sonobe; Jun Sato; Koji Yamanaka; Gen Sobue; Tetsuya Mizuno; Akio Suzumura
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.